πŸ‡ΊπŸ‡Έ FDA
Patent

US 7825216

Phenylanine derivatives

granted A61KA61K38/00A61P

Quick answer

US patent 7825216 (Phenylanine derivatives) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/00, A61P, A61P29/00, A61P3/00